Who
Alan L. Rubino
Director
Company insider
Files Form 4 as: Director, Vericel; Director, SANUWAVE Health; CEO, Emisphere Technologies; President and COO, Pharmos.
In numbers
- Trades disclosed
- 82
- Buys
- 2
- Sells
- 0
- Bought
- $12K
- Sold
- $0
- Companies
- 4
- Companies where not an officer
- 2
- First trade
- 22 May 2006
- Last trade
- 29 Apr 2026
- Last filed
- 1 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 29 Apr 2026filed 1 May 2026 | VCEL VericelBiotechnology | SEC FORM 4 Code M | —3,200 | filing |
| 29 Apr 2026filed 1 May 2026 | VCEL Vericeloption or derivative · Biotechnology | SEC FORM 4 Code M | —3,200 at $0.00 | filing |
| 29 Apr 2026filed 1 May 2026 | VCEL Vericeloption or derivative · Biotechnology | SEC FORM 4 Code A | —8,000 at $0.00 | filing |
| 29 Apr 2026filed 1 May 2026 | VCEL Vericeloption or derivative · Biotechnology | SEC FORM 4 Code M | —3,200 at $0.00 | filing |
| 29 Apr 2026filed 1 May 2026 | VCEL Vericeloption or derivative · Biotechnology | SEC FORM 4 Code A | —8,000 at $0.00 | filing |
| 29 Apr 2026filed 1 May 2026 | VCEL Vericeloption or derivative · Biotechnology | SEC FORM 4 Code A | —3,200 at $0.00 | filing |
| 29 Apr 2026filed 1 May 2026 | VCEL Vericeloption or derivative · Biotechnology | SEC FORM 4 Code A | —3,200 at $0.00 | filing |
| 29 Apr 2026filed 1 May 2026 | VCEL VericelBiotechnology | SEC FORM 4 Code M | —3,200 | filing |
| 25 Mar 2026filed 27 Mar 2026 | VCEL VericelBiotechnology | SEC FORM 4 Code M | $41K15,000 at $2.76 | filing |
| 25 Mar 2026filed 27 Mar 2026 | VCEL Vericeloption or derivative · Biotechnology | SEC FORM 4 Code M | —15,000 at $0.00 | filing |
| 25 Mar 2026filed 27 Mar 2026 | VCEL Vericeloption or derivative · Biotechnology | SEC FORM 4 Code M | —15,000 at $0.00 | filing |
| 25 Mar 2026filed 27 Mar 2026 | VCEL VericelBiotechnology | SEC FORM 4 Code M | $41K15,000 at $2.76 | filing |
| 30 Apr 2025filed 2 May 2025 | VCEL Vericeloption or derivative · Biotechnology | SEC FORM 4 Code M | —3,200 at $0.00 | filing |
| 30 Apr 2025filed 2 May 2025 | VCEL Vericeloption or derivative · Biotechnology | SEC FORM 4 Code A | —8,000 at $0.00 | filing |
| 30 Apr 2025filed 2 May 2025 | VCEL Vericeloption or derivative · Biotechnology | SEC FORM 4 Code A | —3,200 at $0.00 | filing |
| 30 Apr 2025filed 2 May 2025 | VCEL VericelBiotechnology | SEC FORM 4 Code M | —3,200 | filing |
| 7 Feb 2025filed 11 Feb 2025 | VCEL Vericeloption or derivative · Biotechnology | SEC FORM 4 Code M | —4,000 at $0.00 | filing |
| 7 Feb 2025filed 11 Feb 2025 | VCEL Vericeloption or derivative · Biotechnology | SEC FORM 4 Code M | —15,000 at $0.00 | filing |
| 7 Feb 2025filed 11 Feb 2025 | VCEL VericelBiotechnology | SEC FORM 4 Code M | $15K4,000 at $3.74 | filing |
| 7 Feb 2025filed 11 Feb 2025 | VCEL VericelBiotechnology | SEC FORM 4 Code M | $56K15,000 at $3.74 | filing |
News
No headline names them, or the companies they trade most, lately.